Advanced search
Publication Cover
Current Medical Research and Opinion Volume 37, 2021 - Issue 5
Submit an article Journal homepage
439
Views
10
CrossRef citations to date
0
Altmetric
Hematology

Healthcare resource utilization and costs among patients with steroid-resistant chronic graft-versus-host disease in the United States: a retrospective claims database analysis

Jingbo Yua Incyte Corporation, Wilmington, DE, USACorrespondence[email protected]
,
Lincy S. Lalb Optum, Inc., Eden Prairie, MN, USA
,
Amy Andersonb Optum, Inc., Eden Prairie, MN, USA
,
Mary DuCharmeb Optum, Inc., Eden Prairie, MN, USA
,
Shreekant Parasuramana Incyte Corporation, Wilmington, DE, USA
&
Daniel Weisdorfc Department of Medicine, University of Minnesota, Minneapolis, MN, USA
Pages 755-759 | Received 02 Oct 2020, Accepted 18 Feb 2021, Published online: 10 Mar 2021

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Amandeep Salhotra, Karamjeet Sandhu, James O’Hearn, Haris Ali, Ryotaro Nakamura & Badri G Modi. (2023) A critical review of belumosudil in adult and pediatric patients with chronic graft-versus-host disease. Expert Review of Clinical Immunology 19:3, pages 241-251.
Read now

Articles from other publishers (9)

Emily Baumrin, Daniel B. Shin, Nandita Mitra, Joseph Pidala, Najla El Jurdi, Stephanie J. Lee, Alison W. Loren & Joel M. Gelfand. (2024) Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease. JAMA Dermatology 160:4, pages 393.
Crossref
Richard T. Maziarz, Usama Gergis, Marie Louise Edwards, Yan Song, Qing Liu, Annika Anderson, James Signorovitch, Rocio Manghani, Ronit Simantov, Heayoung Shin & Smitha Sivaraman. (2024) Health care costs among patients with hematologic malignancies receiving allogeneic transplants: a US payer perspective. Blood Advances 8:5, pages 1200-1208.
Crossref
Idoroenyi Amanam, Salman Otoukesh, Monzr M. Al Malki & Amandeep Salhotra. (2023) Chronic GVHD: review advances in prevention, novel endpoints, and targeted strategies. Hematology 2023:1, pages 164-170.
Crossref
Navneet S. Majhail, Beckley Miller, Rebecca Dean, Rocio Manghani, Heayoung Shin, Smitha Sivaraman & Richard T. Maziarz. (2023) Hospitalization and Healthcare Resource Utilization of Omidubicel-Onlv versus Umbilical Cord Blood Transplantation for Hematologic Malignancies: Secondary Analysis from a Pivotal Phase 3 Clinical Trial. Transplantation and Cellular Therapy 29:12, pages 749.e1-749.e5.
Crossref
Jian Chun Matthew Ong, Hein Than, Sandeep Tripathi, Christina Gkitzia & Xiaojun Wang. (2023) A cost-effectiveness analysis of ruxolitinib versus best alternative therapy for patients with steroid-refractory chronic graft-versus-host disease aged > 12 years in Singapore. Cost Effectiveness and Resource Allocation 21:1.
Crossref
Christof Scheid, Robert Kudernatsch, Marie Eckart, Chiara Feig, Vincent Straub, Berit Libutzki & Jörg Mahlich. (2022) Treatment Pathways and Health Outcomes of German Patients with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Health Claims Data Analysis. Drugs - Real World Outcomes 9:4, pages 577-588.
Crossref
Sabina De Geest, Sabine Valenta, Janette Ribaut, Sabine Gerull, Juliane Mielke, Michael Simon, Jana Bartakova, Klaus Kaier, Jens Eckstein, Lynn Leppla & Alexandra Teynor. (2022) The SMILe integrated care model in allogeneic SteM cell TransplantatIon faciLitated by eHealth: a protocol for a hybrid effectiveness-implementation randomised controlled trial. BMC Health Services Research 22:1.
Crossref
Betty K. Hamilton, Corey Cutler, Clint Divine, Mark Juckett, Charles LeMaistre, Susan Stewart, Jennifer Wilder, Mary Horowitz, Nandita Khera & Linda J. Burns. (2022) Are We Making PROGRESS in Preventing Graft-versus-Host Disease and Improving Clinical Outcomes? Impact of BMT CTN 1301 Study Results on Clinical Practice. Transplantation and Cellular Therapy 28:8, pages 419-425.
Crossref
Deborah S. Hooker, Kristin Grabe-Heyne, Christof Henne, Peter Bader, Mondher Toumi & Stephen J. Furniss. (2021) Improved Therapeutic Approaches are Needed to Manage Graft-versus-Host Disease. Clinical Drug Investigation 41:11, pages 929-939.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.